Evaluation of Probiotic Properties of Novel Brazilian Lactiplantibacillus plantarum Strains.
Anti-inflammatory effect
Antimicrobial activity
Intestinal mucositis
Lactic acid bacteria
Probiotic potential
Stress tolerance
Journal
Probiotics and antimicrobial proteins
ISSN: 1867-1314
Titre abrégé: Probiotics Antimicrob Proteins
Pays: United States
ID NLM: 101484100
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
accepted:
15
08
2022
pubmed:
27
8
2022
medline:
18
1
2023
entrez:
26
8
2022
Statut:
ppublish
Résumé
Beneficial effects of Lactiplantibacillus plantarum strains have been widely reported. Knowing that the effects of probiotic bacteria are strain-dependent, this study aimed to characterize the probiotic properties and investigate the gastrointestinal protective effects of nine novel L. plantarum strains isolated from Bahia, Brazil. The probiotic functionality was first evaluated in vitro by characterizing bile salt and acidic tolerance, antibacterial activity, and adhesion to Caco-2 cells. Antibiotic resistance profile, mucin degradation, and hemolytic activity assays were also performed to evaluate safety features. In vivo analyses were conducted to investigate the anti-inflammatory effects of the strains on a mouse model of 5-Fluorouracil-induced mucositis. Our results suggest that the used L. plantarum strains have good tolerance to bile salts and low pH and can inhibit commonly gastrointestinal pathogens. Lp2 and Lpl1 strains also exhibited high adhesion rates to Caco-2 cells (13.64 and 9.05%, respectively). Phenotypical resistance to aminoglycosides, vancomycin, and tetracycline was observed for most strains. No strain showed hemolytic or mucolytic activity. Seven strains had a protective effect against histopathological and inflammatory damage induced by 5-FU. Gene expression analysis of inflammatory markers showed that five strains upregulated interleukin 10 (Il10), while four downregulated both interleukin 6 (Il6) and interleukin 1b (Il1b). Additionally, all strains reduced eosinophilic and neutrophilic infiltration; however, they could not prevent weight loss or reduced liquid/ food intake. Altogether, our study suggests these Brazilian L. plantarum strains present good probiotic characteristics and safety levels for future applications and can be therapeutically adjuvant alternatives to prevent/treat intestinal mucositis.
Identifiants
pubmed: 36028786
doi: 10.1007/s12602-022-09978-6
pii: 10.1007/s12602-022-09978-6
doi:
Substances chimiques
Anti-Bacterial Agents
0
Fluorouracil
U3P01618RT
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
160-174Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Hill C, Guarner F, Reid G et al (2014) The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11:506–514. https://doi.org/10.1038/nrgastro.2014.66
doi: 10.1038/nrgastro.2014.66
Markowiak P, Śliżewska K (2017) Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients 9:1021. https://doi.org/10.3390/nu9091021
doi: 10.3390/nu9091021
Klein G, Pack A, Bonaparte C, Reuter G (1998) Taxonomy and physiology of probiotic lactic acid bacteria. Int J Food Microbiol 41:103–125. https://doi.org/10.1016/S0168-1605(98)00049-X
doi: 10.1016/S0168-1605(98)00049-X
Zheng J, Wittouck S, Salvetti E et al (2020) A taxonomic note on the genus Lactobacillus: Description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae. Int J Syst Evol Microbiol 70:2782–2858. https://doi.org/10.1099/ijsem.0.004107
doi: 10.1099/ijsem.0.004107
Crittenden RG, Martinez NR, Playne MJ (2003) Synthesis and utilisation of folate by yoghurt starter cultures and probiotic bacteria. Int J Food Microbiol 80:217–222. https://doi.org/10.1016/S0168-1605(02)00170-8
doi: 10.1016/S0168-1605(02)00170-8
Saier MH Jr, Mansour NM (2005) Probiotics and prebiotics in Human Health. J Mol Microbiol Biotechnol 10:22–25. https://doi.org/10.1159/000090345
doi: 10.1159/000090345
Liu Y-W, Liong M-T, Tsai Y-C (2018) New perspectives of Lactobacillus plantarum as a probiotic: The gut-heart-brain axis. J Microbiol 56:601–613. https://doi.org/10.1007/s12275-018-8079-2
doi: 10.1007/s12275-018-8079-2
Li S, Huang R, Shah NP et al (2014) Antioxidant and antibacterial activities of exopolysaccharides from Bifidobacterium bifidum WBIN03 and Lactobacillus plantarum R315. J Dairy Sci 97:7334–7343. https://doi.org/10.3168/jds.2014-7912
doi: 10.3168/jds.2014-7912
Hu C, Ren L, Zhou Y, Ye B (2019) Characterization of antimicrobial activity of three Lactobacillus plantarum strains isolated from Chinese traditional dairy food. Food Sci Nutr 7:1997–2005. https://doi.org/10.1002/fsn3.1025
doi: 10.1002/fsn3.1025
Park S, Ji Y, Jung H-Y et al (2017) Lactobacillus plantarum HAC01 regulates gut microbiota and adipose tissue accumulation in a diet-induced obesity murine model. Appl Microbiol Biotechnol 101:1605–1614. https://doi.org/10.1007/s00253-016-7953-2
doi: 10.1007/s00253-016-7953-2
Lim S-D, Kim S, Huang E et al (2018) Physiological characteristics and anti-obesity effect of Lactobacillus plantarum K10. Korean J Food Sci An 38:2234–2246. https://doi.org/10.5851/kosfa.2018.38.3.554
doi: 10.5851/kosfa.2018.38.3.554
Fuentes MC, Lajo T, Carrión JM, Cuñé J (2013) Cholesterol-lowering efficacy of Lactobacillus plantarum CECT 7527, 7528 and 7529 in hypercholesterolaemic adults. Br J Nutr 109:1866–1872. https://doi.org/10.1017/S000711451200373X
doi: 10.1017/S000711451200373X
Le B, Yang SH (2018) Efficacy of Lactobacillus plantarum in prevention of inflammatory bowel disease. Toxicol Reports 5:314–317. https://doi.org/10.1016/j.toxrep.2018.02.007
doi: 10.1016/j.toxrep.2018.02.007
Zhang F, Li Y, Wang X et al (2019) The Impact of Lactobacillus plantarum on the Gut microbiota of mice with DSS-induced colitis. Biomed Res Int 2019:1–10. https://doi.org/10.1155/2019/3921315
doi: 10.1155/2019/3921315
Yue Y, Ye K, Lu J et al (2020) Probiotic strain Lactobacillus plantarum YYC-3 prevents colon cancer in mice by regulating the tumour microenvironment. Biomed Pharmacother 127:110159. https://doi.org/10.1016/j.biopha.2020.110159
doi: 10.1016/j.biopha.2020.110159
Tallon R, Arias S, Bressollier P, Urdaci MC (2007) Strain- and matrix-dependent adhesion of Lactobacillus plantarum is mediated by proteinaceous bacterial compounds. J Appl Microbiol 102:442–451. https://doi.org/10.1111/j.1365-2672.2006.03086.x
doi: 10.1111/j.1365-2672.2006.03086.x
Batista VL, da Silva TF, de Jesus LCL et al (2020) Probiotics, prebiotics, synbiotics, and paraprobiotics as a therapeutic alternative for intestinal mucositis. Front Microbiol 11:544490. https://doi.org/10.3389/fmicb.2020.544490
doi: 10.3389/fmicb.2020.544490
Yeung C-Y, Chan W-T, Jiang C-B et al (2015) Amelioration of chemotherapy-induced intestinal mucositis by orally administered probiotics in a mouse model. PLoS ONE 10:e0138746. https://doi.org/10.1371/journal.pone.0138746
doi: 10.1371/journal.pone.0138746
Tang Y, Wu Y, Huang Z et al (2017) Administration of probiotic mixture DM#1 ameliorated 5-fluorouracil–induced intestinal mucositis and dysbiosis in rats. Nutrition 33:96–104. https://doi.org/10.1016/j.nut.2016.05.003
doi: 10.1016/j.nut.2016.05.003
Quaresma M, Damasceno S, Monteiro C et al (2020) Probiotic mixture containing Lactobacillus spp. and Bifidobacterium spp. attenuates 5-fluorouracil-induced intestinal mucositis in mice. Nutr Cancer 72:1355–1365. https://doi.org/10.1080/01635581.2019.1675719
doi: 10.1080/01635581.2019.1675719
Sougiannis AT, VanderVeen BN, Davis JM et al (2021) Understanding chemotherapy-induced intestinal mucositis and strategies to improve gut resilience. Am J Physiol Liver Physiol 320:G712–G719. https://doi.org/10.1152/ajpgi.00380.2020
doi: 10.1152/ajpgi.00380.2020
Dahlgren D, Sjöblom M, Hellström PM, Lennernäs H (2021) Chemotherapeutics-Induced intestinal mucositis: pathophysiology and potential treatment strategies. Front Pharmacol 12:681417. https://doi.org/10.3389/fphar.2021.681417
doi: 10.3389/fphar.2021.681417
Cinausero M, Aprile G, Ermacora P et al (2017) New frontiers in the pathobiology and treatment of cancer regimen-related mucosal injury. Front Pharmacol 8:354. https://doi.org/10.3389/fphar.2017.00354
doi: 10.3389/fphar.2017.00354
Stringer AM (2013) Interaction between host cells and microbes in chemotherapy-induced mucositis. Nutrients 5:1488–1499. https://doi.org/10.3390/nu5051488
doi: 10.3390/nu5051488
Touchefeu Y, Montassier E, Nieman K et al (2014) Systematic review: the role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis - current evidence and potential clinical applications. Aliment Pharmacol Ther 40:409–421. https://doi.org/10.1111/apt.12878
doi: 10.1111/apt.12878
Gori S, Inno A, Belluomini L et al (2019) Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy. Crit Rev Oncol Hematol 143:139–147. https://doi.org/10.1016/j.critrevonc.2019.09.003
doi: 10.1016/j.critrevonc.2019.09.003
Levit R, Savoy de Giori G, de Moreno de LeBlanc A, LeBlanc JG (2018) Protective effect of the riboflavin-overproducing strain Lactobacillus plantarum CRL2130 on intestinal mucositis in mice. Nutrition 54:165–172. https://doi.org/10.1016/j.nut.2018.03.056
doi: 10.1016/j.nut.2018.03.056
Ciobanu L, Tefas C, Oancea D et al (2020) Effect of Lactobacillus plantarum ACTT 8014 on 5-fluorouracil induced intestinal mucositis in Wistar rats. Exp Ther Med 20:1–1. https://doi.org/10.3892/etm.2020.9339
doi: 10.3892/etm.2020.9339
Tokatlı M, Gülgör G, Bağder Elmacı S et al (2015) In vitro properties of potential probiotic indigenous lactic acid bacteria originating from traditional pickles. Biomed Res Int 2015:1–8. https://doi.org/10.1155/2015/315819
doi: 10.1155/2015/315819
Walker DK, Gilliland SE (1993) Relationships among bile tolerance, bile salt deconjugation, and assimilation of cholesterol by Lactobacillus acidophilus. J Dairy Sci 76:956–961. https://doi.org/10.3168/jds.S0022-0302(93)77422-6
doi: 10.3168/jds.S0022-0302(93)77422-6
Toure R, Kheadr E, Lacroix C et al (2003) Production of antibacterial substances by bifidobacterial isolates from infant stool active against Listeria monocytogenes. J Appl Microbiol 95:1058–1069. https://doi.org/10.1046/j.1365-2672.2003.02085.x
doi: 10.1046/j.1365-2672.2003.02085.x
Nami Y, Abdullah N, Haghshenas B et al (2014) Probiotic assessment of Enterococcus durans 6HL and Lactococcus lactis 2HL isolated from vaginal microflora. J Med Microbiol 63:1044–1051. https://doi.org/10.1099/jmm.0.074161-0
doi: 10.1099/jmm.0.074161-0
Clinical and Laboratory Standards Institute (CLSI) (2018) Performance standards for antimicrobial susceptibility testing. 28th ed. CSLI supplement M100. Wayne, PA. Diponible in: https://file.qums.ac.ir/repository/mmrc/CLSI-2018-M100-S28.pdf
Zhou JS, Gopal PK, Gill HS (2001) Potential probiotic lactic acid bacteria Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019) do not degrade gastric mucin in vitro. Int J Food Microbiol 63:81–90. https://doi.org/10.1016/S0168-1605(00)00398-6
doi: 10.1016/S0168-1605(00)00398-6
Xu L, Yuan J, Chen X et al (2021) Screening of intestinal probiotics and the effects of feeding probiotics on the digestive enzyme activity, immune, intestinal flora and WSSV resistance of Procambarus clarkii. Aquaculture 540:736748. https://doi.org/10.1016/j.aquaculture.2021.736748
doi: 10.1016/j.aquaculture.2021.736748
Carvalho RD, Breyner N, Menezes-Garcia Z et al (2017) Secretion of biologically active pancreatitis-associated protein I (PAP) by genetically modified dairy Lactococcus lactis NZ9000 in the prevention of intestinal mucositis. Microb Cell Fact 16:27. https://doi.org/10.1186/s12934-017-0624-x
doi: 10.1186/s12934-017-0624-x
Soares PMG, Mota JMSC, Gomes AS et al (2008) Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution. Cancer Chemother Pharmacol 63:91–98. https://doi.org/10.1007/s00280-008-0715-9
doi: 10.1007/s00280-008-0715-9
De Jesus LCL, Drumond MM, de Carvalho A et al (2019) Protective effect of Lactobacillus delbrueckii subsp. lactis CIDCA 133 in a model of 5 Fluorouracil-Induced intestinal mucositis. J Funct Foods 53:197–207. https://doi.org/10.1016/j.jff.2018.12.027
doi: 10.1016/j.jff.2018.12.027
Rychen G, Aquilina G, Azimonti G et al (2018) Guidance on the characterisation of microorganisms used as feed additives or as production organisms. EFSA J. https://doi.org/10.2903/j.efsa.2018.5206
doi: 10.2903/j.efsa.2018.5206
Anvisa (2021) Guia de Instrução Processual de Petição de Avaliação de Probióticos para Uso em Alimentos. In: Guid. no 21/2021 – version 2. Disponible in: http://antigo.anvisa.gov.br/documents/10181/5280930/guia+21+v2.pdf/dac5bf5f-ae56-4444-b53c-2cf0f7c15301
Papadimitriou K, Alegría Á, Bron PA et al (2016) Stress physiology of lactic acid bacteria. Microbiol Mol Biol Rev 80:837–890. https://doi.org/10.1128/MMBR.00076-15
doi: 10.1128/MMBR.00076-15
Haghshenas B, Nami Y, Almasi A et al (2017) Isolation and characterization of probiotics from dairies. Iran J Microbiol 9:234–243
Nath S, Sikidar J, Roy M, Deb B (2020) In vitro screening of probiotic properties of Lactobacillus plantarum isolated from fermented milk product Graphical Abstract. Food Qual Saf 4:213–223. https://doi.org/10.1093/fqsafe/fyaa026
doi: 10.1093/fqsafe/fyaa026
Riane K (2019) Probiotic properties and antioxidant efficiency of Lactobacillus plantarum 15 isolated from milk. J Microbiol Biotechnol Food Sci 9:516–520. https://doi.org/10.15414/jmbfs.2019/20.9.3.516-520
Jacobsen CN, Rosenfeldt Nielsen V, Hayford AE et al (1999) Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by In vitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl Environ Microbiol 65:4949–4956. https://doi.org/10.1128/AEM.65.11.4949-4956.1999
doi: 10.1128/AEM.65.11.4949-4956.1999
Servin AL, Coconnier M-H (2003) Adhesion of probiotic strains to the intestinal mucosa and interaction with pathogens. Best Pract Res Clin Gastroenterol 17:741–754. https://doi.org/10.1016/S1521-6918(03)00052-0
doi: 10.1016/S1521-6918(03)00052-0
Monteagudo-Mera A, Rastall RA, Gibson GR et al (2019) Adhesion mechanisms mediated by probiotics and prebiotics and their potential impact on human health. Appl Microbiol Biotechnol 103:6463–6472. https://doi.org/10.1007/s00253-019-09978-7
doi: 10.1007/s00253-019-09978-7
Velez MP, De Keersmaecker SCJ, Vanderleyden J (2007) Adherence factors of Lactobacillus in the human gastrointestinal tract. FEMS Microbiol Lett 276:140–148. https://doi.org/10.1111/j.1574-6968.2007.00908.x
doi: 10.1111/j.1574-6968.2007.00908.x
Sharma S, Kanwar SS (2017) Adherence potential of indigenous lactic acid bacterial isolates obtained from fermented foods of Western Himalayas to intestinal epithelial Caco-2 and HT-29 cell lines. J Food Sci Technol 54:3504–3511. https://doi.org/10.1007/s13197-017-2807-1
doi: 10.1007/s13197-017-2807-1
García-Ruiz A, González de Llano D, Esteban-Fernández A et al (2014) Assessment of probiotic properties in lactic acid bacteria isolated from wine. Food Microbiol 44:220–225. https://doi.org/10.1016/j.fm.2014.06.015
doi: 10.1016/j.fm.2014.06.015
Alizadeh Behbahani B, Noshad M, Falah F (2019) Inhibition of Escherichia coli adhesion to human intestinal Caco-2 cells by probiotic candidate Lactobacillus plantarum strain L15. Microb Pathog 136:103677. https://doi.org/10.1016/j.micpath.2019.103677
doi: 10.1016/j.micpath.2019.103677
Zhang Y-C, Zhang L-W, Ma W et al (2012) Screening of probiotic lactobacilli for inhibition of Shigella sonnei and the macromolecules involved in inhibition. Anaerobe 18:498–503. https://doi.org/10.1016/j.anaerobe.2012.08.007
doi: 10.1016/j.anaerobe.2012.08.007
de Castilho NPA, Todorov SD, Oliveira LL et al (2020) Inhibition of Listeria monocytogenes in fresh sausage by bacteriocinogenic Lactobacillus curvatus UFV-NPAC1 and its semi-purified bacteriocin. LWT 118:108757. https://doi.org/10.1016/j.lwt.2019.108757
doi: 10.1016/j.lwt.2019.108757
Bohora AA, Kokate SR (2017) Good Bugs vs Bad Bugs: evaluation of inhibitory effect of selected probiotics against Enterococcus faecalis. J Contemp Dent Pract 18:312–316. https://doi.org/10.5005/jp-journals-10024-2037
doi: 10.5005/jp-journals-10024-2037
Halder D, Mandal M, Chatterjee S et al (2017) Indigenous probiotic Lactobacillus isolates presenting antibiotic like activity against human pathogenic bacteria. Biomedicines 5:31. https://doi.org/10.3390/biomedicines5020031
doi: 10.3390/biomedicines5020031
Zangeneh M, Khorrami S, Khaleghi M (2020) Bacteriostatic activity and partial characterization of the bacteriocin produced by L. plantarum sp. isolated from traditional sourdough. Food Sci Nutr 8:6023–6030. https://doi.org/10.1002/fsn3.1890
doi: 10.1002/fsn3.1890
de Sousa MA, Rama GR, Volken de Souza CF, Granada CE (2020) Acid lactic lactobacilli as a biotechnological toll to improve food quality and human health. Biotechnol Prog. https://doi.org/10.1002/btpr.2937
doi: 10.1002/btpr.2937
Cazorla SI, Maldonado-Galdeano C, Weill R et al (2018) Oral Administration of probiotics increases paneth cells and intestinal antimicrobial activity. Front Microbiol 9:736. https://doi.org/10.3389/fmicb.2018.00736
doi: 10.3389/fmicb.2018.00736
Campana R, van Hemert S, Baffone W (2017) Strain-specific probiotic properties of lactic acid bacteria and their interference with human intestinal pathogens invasion. Gut Pathog 9:12. https://doi.org/10.1186/s13099-017-0162-4
doi: 10.1186/s13099-017-0162-4
Hernández-González JC, Martínez-Tapia A, Lazcano-Hernández G et al (2021) Bacteriocins from Lactic Acid Bacteria. A powerful alternative as antimicrobials, probiotics, and immunomodulators in veterinary medicine. Animals 11:979. https://doi.org/10.3390/ani11040979
Ibrahim SA, Ayivi RD, Zimmerman T et al (2021) Lactic acid bacteria as antimicrobial agents: food safety and microbial food spoilage prevention. Foods 10:3131. https://doi.org/10.3390/foods10123131
doi: 10.3390/foods10123131
Ołdak A, Zielińska D (2017) Bacteriocins from lactic acid bacteria as an alternative to antibiotics. Postepy Hig Med Dosw. https://doi.org/10.5604/01.3001.0010.3817
doi: 10.5604/01.3001.0010.3817
Taverniti V, Stuknyte M, Minuzzo M et al (2013) S-layer protein mediates the stimulatory effect of Lactobacillus helveticus MIMLh5 on innate immunity. Appl Environ Microbiol 79:1221–1231. https://doi.org/10.1128/AEM.03056-12
doi: 10.1128/AEM.03056-12
Haller D, Bode C, Hammes WP et al (2000) Non-pathogenic bacteria elicit a diferential cytokine response by intestinal epithelial cell/leucocyte co-cultures. Gut 47:79–87. https://doi.org/10.1136/gut.47.1.79
doi: 10.1136/gut.47.1.79
Sonis ST, Tracey C, Shklar G et al (1990) An animal model for mucositis induced by cancer chemotherapy. Oral Surgery, Oral Med Oral Pathol 69:437–443. https://doi.org/10.1016/0030-4220(90)90376-4
doi: 10.1016/0030-4220(90)90376-4
Trindade LM, Torres L, Matos ID et al (2021) Paraprobiotic Lacticaseibacillus rhamnosus Protects intestinal damage in an experimental murine model of mucositis. Probiotics Antimicrob Proteins. https://doi.org/10.1007/s12602-021-09842-z
Coutinho JOPA, Quintanilha MF, Campos MRA et al (2021) Antarctic strain of Rhodotorula mucilaginosa UFMGCB 18,377 Attenuates mucositis induced by 5-fluorouracil in mice. Probiotics Antimicrob Proteins. https://doi.org/10.1007/s12602-021-09817-0
doi: 10.1007/s12602-021-09817-0
Barroso FAL, de Jesus LCL, da Silva TF et al (2022) Lactobacillus delbrueckii CIDCA 133 Ameliorates chemotherapy-induced mucositis by modulating epithelial barrier and TLR2/4/Myd88/NF-κB signaling pathway. Front Microbiol. https://doi.org/10.3389/fmicb.2022.858036
doi: 10.3389/fmicb.2022.858036
Quintanilha MF, Miranda VC, Souza RO et al (2022) Bifidobacterium longum subsp. longum 51A attenuates intestinal injury against irinotecan-induced mucositis in mice. Life Sci 289:120243. https://doi.org/10.1016/j.lfs.2021.120243
Sonis ST (2004) The pathobiology of mucositis. Nat Rev Cancer 4:277–284. https://doi.org/10.1038/nrc1318
doi: 10.1038/nrc1318
Denning TL, Campbell NA, Song F et al (2000) Expression of IL-10 receptors on epithelial cells from the murine small and large intestine. Int Immunol 12:133–139. https://doi.org/10.1093/intimm/12.2.133
doi: 10.1093/intimm/12.2.133
Jarry A, Bossard C, Bou-Hanna C et al (2008) Mucosal IL-10 and TGF-β play crucial roles in preventing LPS-driven, IFN-γ-mediated epithelial damage in human colon explants. J Clin Invest. https://doi.org/10.1172/JCI32140
doi: 10.1172/JCI32140
Justino PF, Melo LF, Nogueira AF, Morais C et al (2015) Regulatory role of Lactobacillus acidophilus on inflammation and gastric dysmotility in intestinal mucositis induced by 5-fluorouracil in mice. Cancer Chemother Pharmacol 3:559–567. https://doi.org/10.1007/s00280-014-2663-x
doi: 10.1007/s00280-014-2663-x
Oh NS, Lee JY, Lee JM et al (2017) Mulberry leaf extract fermented with Lactobacillus acidophilus A4 ameliorates 5-fluorouracil-induced intestinal mucositis in rats. Lett Appl Microbiol 64:459–468. https://doi.org/10.1111/lam.12741
doi: 10.1111/lam.12741
Sengupta R, Altermann E, Anderson RC et al (2013) The Role of cell surface architecture of Lactobacilli in host-microbe interactions in the gastrointestinal tract. Mediators Inflamm 2013:1–16. https://doi.org/10.1155/2013/237921
doi: 10.1155/2013/237921
Chandhni PR, Pradhan D, Sowmya K et al (2021) Ameliorative effect of surface proteins of probiotic lactobacilli in colitis mouse models. Front Microbiol. https://doi.org/10.3389/fmicb.2021.679773
doi: 10.3389/fmicb.2021.679773
De Jesus LCL, Aburjaile FF, Sousa TDJ et al (2022) Genomic characterization of Lactobacillus delbrueckii strains with probiotics properties. Front Bioinforma. https://doi.org/10.3389/fbinf.2022.912795
doi: 10.3389/fbinf.2022.912795
Ruiz L, Hevia A, Bernardo D et al (2014) Extracellular molecular effectors mediating probiotic attributes. FEMS Microbiol Lett 359:1–11. https://doi.org/10.1111/1574-6968.12576
doi: 10.1111/1574-6968.12576
Delgado S, Sánchez B, Margolles A et al (2020) Molecules produced by probiotics and intestinal microorganisms with immunomodulatory activity. Nutrients 12:391. https://doi.org/10.3390/nu12020391
doi: 10.3390/nu12020391
Gupta N, Ferreira J, Hsu C et al (2020) Lactobacillus reuteri DSM 17938 and ATCC PTA 5289 ameliorates chemotherapy-induced oral mucositis. Sci Reports 10:16189. https://doi.org/10.1038/s41598-020-73292-w
doi: 10.1038/s41598-020-73292-w
Bowen JM, Stringer AM, Gibson RJ et al (2007) VSL#3 probiotic treatment reduces chemotherapy-induced diarrhoea and weight loss. Cancer Biol Ther 6:1445–1450. https://doi.org/10.4161/cbt.6.9.4622
doi: 10.4161/cbt.6.9.4622
de Jesus LCL, de Jesus Sousa T, Coelho-Rocha ND et al (2021) Safety evaluation of Lactobacillus delbrueckii subsp. lactis CIDCA 133: a health-promoting bacteria. Probiotics Antimicrob Proteins. https://doi.org/10.1007/s12602-021-09826-z
Chokesajjawatee N, Santiyanont P, Chantarasakha K et al (2020) Safety Assessment of a nham starter culture Lactobacillus plantarum BCC9546 via Whole-genome Analysis. Sci Rep 10:10241. https://doi.org/10.1038/s41598-020-66857-2
doi: 10.1038/s41598-020-66857-2
Toropov V, Demyanova E, Shalaeva O et al (2020) Whole-genome sequencing of Lactobacillus helveticus D75 and D76 confirms safety and probiotic potential. Microorganisms 8:329. https://doi.org/10.3390/microorganisms8030329
doi: 10.3390/microorganisms8030329
Hummel AS, Hertel C, Holzapfel WH, Franz CMAP (2007) Antibiotic Resistances of starter and probiotic strains of lactic acid bacteria. Appl Environ Microbiol 73:730–739. https://doi.org/10.1128/AEM.02105-06
doi: 10.1128/AEM.02105-06
Anisimova EA, Yarullina DR (2019) Antibiotic resistance of Lactobacillus Strains. Curr Microbiol 76:1407–1416. https://doi.org/10.1007/S00284-019-01769-7
doi: 10.1007/S00284-019-01769-7
Campedelli I, Mathur H, Salvetti E et al (2019) Genus-Wide assessment of antibiotic resistance in Lactobacillus spp. Appl Environ Microbiol. https://doi.org/10.1128/AEM.01738-18
doi: 10.1128/AEM.01738-18
Goldstein EJC, Tyrrell KL, Citron DM (2015) Lactobacillus Species: taxonomic complexity and controversial susceptibilities. Clin Infect Dis 60:S98–S107. https://doi.org/10.1093/cid/civ072
doi: 10.1093/cid/civ072
Das DJ, Shankar A, Johnson JB, Thomas S (2020) Critical insights into antibiotic resistance transferability in probiotic Lactobacillus. Nutrition 69:110567. https://doi.org/10.1016/j.nut.2019.110567
doi: 10.1016/j.nut.2019.110567
Sharma P, Tomar SK, Goswami P et al (2014) Antibiotic resistance among commercially available probiotics. Food Res Int 57:176–195. https://doi.org/10.1016/j.foodres.2014.01.025
doi: 10.1016/j.foodres.2014.01.025